Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Top Cited Papers
Open Access
- 6 February 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 100 (3), 170-183
- https://doi.org/10.1093/jnci/djm323
Abstract
Sex hormones in serum have been hypothesized to influence the risk of prostate cancer. We performed a collaborative analysis of the existing worldwide epidemiologic data to examine these associations in a uniform manner and to provide more precise estimates of risks. Data on serum concentrations of sex hormones from 18 prospective studies that included 3886 men with incident prostate cancer and 6438 control subjects were pooled by the Endogenous Hormones and Prostate Cancer Collaborative Group. Relative risks (RRs) of prostate cancer by fifths of serum hormone concentration were estimated by use of conditional logistic regression with stratification by study, age at recruitment, and year of recruitment. All statistical tests were two-sided. No associations were found between the risk of prostate cancer and serum concentrations of testosterone, calculated free testosterone, dihydrotestosterone, dehydroepiandrosterone sulfate, androstenedione, androstanediol glucuronide, estradiol, or calculated free estradiol. The serum concentration of sex hormone–binding globulin was modestly inversely associated with prostate cancer risk (RR in the highest vs lowest fifth = 0.86, 95% confidence interval = 0.75 to 0.98; Ptrend = .01). There was no statistical evidence of heterogeneity among studies, and adjustment for potential confounders made little difference to the risk estimates. In this collaborative analysis of the worldwide data on endogenous hormones and prostate cancer risk, serum concentrations of sex hormones were not associated with the risk of prostate cancer.Keywords
This publication has 53 references indexed in Scilit:
- Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and NutritionInternational Journal of Cancer, 2007
- Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone TherapyCancer Epidemiology, Biomarkers & Prevention, 2005
- The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Prostate cancer association studies: Pitfalls and solutions to cancer misclassification in the PSA eraJournal of Cellular Biochemistry, 2003
- High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective studyInternational Journal of Cancer, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Longitudinal evaluation of serum androgen levels in men with and without prostate cancerThe Prostate, 1995
- Synthesis of new steroid haptens for radioimmunoassay—VIII. Development and validation of a specific radioimmunoassay for serum 5α-androstane-3α,17β-diol 17-glucuronideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Isolation and identification of androstanediol glucuronide from human plasmaThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperatureThe Journal of Steroid Biochemistry and Molecular Biology, 1982